| Revenue growth | -10% YoY consolidated; exports volume down 8%. |
|---|---|
| Margins | EBITDA margin at 22% vs 27% YoY; gross margins impacted. |
| Order book | Continues to support growth outlook for new products. |
| Demand visibility | Soft global agrochemical demand; domestic volume up 12%. |
| Management confidence | Long-term outlook remains intact despite current cyclical headwinds. |
Growth
Exports revenue declined 13.3% YoY on soft global demand; domestic revenue grew 2.8% with biologicals up 50%+
Outlook
Launching 5+ new products in FY27; ₹2,685 Mn capex in Q1; net cash balance increased to ₹37,939 Mn.
Risks
Pricing pressure from generics, delayed monsoon impacting Kharif sowing, and geopolitical tensions increasing input material costs.
Last quarter's promises, checked
Delivered
- Guided 25% EBITDA margin for FY26 → delivered 25% (= BEAT)
- Guided sequential revenue growth for Q4 FY26 → delivered Rs. 15,652 Mn (= BEAT)
- Guided Pharma growth → delivered 40% growth for full year (= BEAT)
Partly delivered
- Guided ETR for FY26 at 22% → delivered 22% (but warned of 24% future rise) (= PARTIAL)
Missed
- Guided positive growth for FY27 → delivered -10% revenue in Q1 FY27 (= MISS)
- Guided EBITDA margin profile → delivered 22% in Q1 FY27 vs 25% FY26 commitment (= MISS)
Investor Presentation filed with BSE, NSE: PIIND. Summary written with AI assistance from the document.
PI Industries Ltd: key numbers
- Share price
- ₹2,205.80
- Market cap
- ₹33,466 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 28.7×Sector 37.2×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.83%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Other Announcement
Bhavina J Dholariya, an immediate relative of an insider, sold equity shares of PI Industries Ltd. The market sale was valued at ₹0.12 Crore.
- Value
- ₹0.12 Cr
PI Industries Product Launch
PI Industries received registration for its indigenously developed insecticide, 'Pioxaniliprole' (branded 'Pioxazon'), marking a key milestone in its agricultural innovation journey.
PI Industries Other Announcement
Designated person Jayesh Dholariya disclosed the sale of 3,000 equity shares via gift, totaling approximately Rs. 0.75 Crore.
- Value
- ₹0.75 Cr
PI Industries Annual General Meeting
PI Industries held its 79th Annual General Meeting on August 14, 2026. Shareholders approved all nine agenda items, including financial statements and dividend payments.
PI Industries Earnings Call Transcript: Key Takeaways
PI Industries Q1 FY27 results show resilience amidst global agrochemical headwinds, maintaining healthy EBITDA margins at 22% despite revenue softness. Management remains optimistic about a second-half recovery driven by domestic monsoon improvement and new product scale-ups.
- Call
- Guides 5% growth
PI Industries Merger & Restructuring Worth ₹0.01 Cr
PI Industries will incorporate 'PI Foundation' as a Section 8 company for CSR activities. The company will invest Rs. 0.01 Crore in cash for the shares.
- Value
- ₹0.01 Cr